Krystal Biotech, Inc. is a company in the U.S. stock market and it is a holding in 35 U.S.-traded ETFs. KRYS has around 893.8K shares in the U.S. ETF market. The largest ETF holder of KRYS is the SPDR S&P Biotech ETF (XBI), with approximately 253.68K shares. Investors may also find of interest that the ETF with the largest allocation to KRYS stock is Invesco DWA NASDAQ Momentum ETF (DWAQ), with a portfolio weight of 2.23%. On average, U.S. ETFs allocate 0.30% of KRYS to their portfolios.
Additionally, KRYS is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with KRYS as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 35.89%.